PREVENTIVE EFFECT OF ATORVASTATIN (80 MG) ON CONTRAST-INDUCED NEPHROPATHY AFTER ANGIOGRAPHY IN HIGH-RISK PATIENTS: DOUBLE-BLIND RANDOMIZED CLINICAL TRIAL

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

KHOSRAVI AREZOO; DOLATKHAH MITRA; SADAT HASHEMI HESAM; ROSTAMI ZOHREH

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Nephro-Urology Monthly Year:2016 | Volume:8 | Issue:3 Page(s): 0-0

Download Full-Text

View:

Download:

Cites:

Information Journal Paper

Title

PREVENTIVE EFFECT OF ATORVASTATIN (80 MG) ON CONTRAST-INDUCED NEPHROPATHY AFTER ANGIOGRAPHY IN HIGH-RISK PATIENTS: DOUBLE-BLIND RANDOMIZED CLINICAL TRIAL

Author(s)

KHOSRAVI AREZOO | DOLATKHAH MITRA | SADAT HASHEMI HESAM | ROSTAMI ZOHREH | Issue Writer Certificate

Keywords

CONTRAST INDUCED NEPHROPATHY

ATORVASTATIN

CHRONIC KIDNEY DISEASE

DIABETES MELLITUS

Abstract

Background: Contrast-induced nephropathy (CIN) is one of the most important complications of angiography in patients with CHRONIC KIDNEY DISEASE (CKD) or DIABETES MELLITUS. The prevention of CIN can decrease therapeutic costs and hospital stays. There is controversy in the literature over the preventive effect of statins on CIN.Objectives: This study was designed to evaluate the preventive effect of ATORVASTATIN on CIN after angiography in CKD and diabetic patients.Patients and Methods: In this placebo-controlled, double-blind clinical trial, patients with DIABETES MELLITUS or CKD (15<GFR<60 mL/min, Cr>1.5 mg/dL) and an age range of 55 - 75 years candidated for angiography were included. The patients were randomized to 2 groups: one group receiving ATORVASTATIN (80 mg/d from 48 h before angiography) and the other one receiving a placebo. All the patients received intravenous isotonic saline and N-acetylcysteine. CIN was defined as an increase in serum creatinine more than 0.5 mg/dL or more than 25% from the baseline values.Results: Totally, 220 patients at a mean age of 63.858.89 years and a mean body mass index of 31.415.99 kg/m2 were evaluated.In comparison of before-after values, there was a significant increase in serum creatinine in the placebo group (P=0.000). The incidence of CIN was significantly higher in the control group 24 hours after angiography (P=0.010); however, at a 48-hour interval, there was no significant difference in CIN between the 2 groups.Conclusions: Standard hydration and N-acetylcysteine and ATORVASTATIN (80 mg) reduced the incidence of CIN, and this regimen was more effective than was the regimen of hydration and N-acetylcysteine (without ATORVASTATIN) in decreasing CIN. Accordingly, it is reasonable to prescribe ATORVASTATIN before angiography in high-risk patients.

Cites

No record.

References

No record.

Cite

APA: Copy

KHOSRAVI, AREZOO, DOLATKHAH, MITRA, SADAT HASHEMI, HESAM, & ROSTAMI, ZOHREH. (). . , (), -. SID. https://sid.ir/paper/323784/en

Vancouver: Copy

KHOSRAVI AREZOO, DOLATKHAH MITRA, SADAT HASHEMI HESAM, ROSTAMI ZOHREH. . [Internet]. ;():-. Available from: https://sid.ir/paper/323784/en

IEEE: Copy

AREZOO KHOSRAVI, MITRA DOLATKHAH, HESAM SADAT HASHEMI, and ZOHREH ROSTAMI, “,” , vol. , no. , pp. –, , [Online]. Available: https://sid.ir/paper/323784/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops